Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Human Parturition Involves Phosphorylation of Progesterone Receptor-A at Serine-345 in Myometrial Cells.

Amini P, Michniuk D, Kuo K, Yi L, Skomorovska-Prokvolit Y, Peters GA, Tan H, Wang J, Malemud CJ, Mesiano S.

Endocrinology. 2016 Nov;157(11):4434-4445. Epub 2016 Sep 21.

PMID:
27653036
3.

Endocrine-disrupting chemicals and uterine fibroids.

Katz TA, Yang Q, Treviño LS, Walker CL, Al-Hendy A.

Fertil Steril. 2016 Sep 15;106(4):967-77. doi: 10.1016/j.fertnstert.2016.08.023. Epub 2016 Aug 21. Review.

PMID:
27553264
4.

Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition.

Menon R, Bonney EA, Condon J, Mesiano S, Taylor RN.

Hum Reprod Update. 2016 Sep;22(5):535-60. doi: 10.1093/humupd/dmw022. Epub 2016 Jun 30. Review.

PMID:
27363410
5.

Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.

Clare SE, Gupta A, Choi M, Ranjan M, Lee O, Wang J, Ivancic DZ, Kim JJ, Khan SA.

BMC Cancer. 2016 May 23;16:326. doi: 10.1186/s12885-016-2355-5.

6.

Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.

Proietti CJ, Izzo F, Díaz Flaqué MC, Cordo Russo R, Venturutti L, Mercogliano MF, De Martino M, Pineda V, Muñoz S, Guzmán P, Roa JC, Schillaci R, Elizalde PV.

Mol Endocrinol. 2015 Oct;29(10):1468-85. doi: 10.1210/me.2015-1170. Epub 2015 Sep 4.

7.

Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.

Schwarzman MR, Ackerman JM, Dairkee SH, Fenton SE, Johnson D, Navarro KM, Osborne G, Rudel RA, Solomon GM, Zeise L, Janssen S.

Environ Health Perspect. 2015 Dec;123(12):1255-64. doi: 10.1289/ehp.1408337. Epub 2015 Jun 2. Review.

8.

Efficient prediction of progesterone receptor interactome using a support vector machine model.

Liu JL, Peng Y, Fu YS.

Int J Mol Sci. 2015 Mar 3;16(3):4774-85. doi: 10.3390/ijms16034774.

9.

Progesterone action in breast, uterine, and ovarian cancers.

Diep CH, Daniel AR, Mauro LJ, Knutson TP, Lange CA.

J Mol Endocrinol. 2015 Apr;54(2):R31-53. doi: 10.1530/JME-14-0252. Epub 2015 Jan 13. Review.

10.

Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Patel B, Elguero S, Thakore S, Dahoud W, Bedaiwy M, Mesiano S.

Hum Reprod Update. 2015 Mar-Apr;21(2):155-73. doi: 10.1093/humupd/dmu056. Epub 2014 Nov 18. Review.

11.

Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.

Moore NL, Edwards DP, Weigel NL.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt B:471-82. doi: 10.1016/j.jsbmb.2014.09.009. Epub 2014 Sep 16.

12.

Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.

Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA.

Mol Endocrinol. 2014 Apr;28(4):442-57. doi: 10.1210/me.2013-1196. Epub 2014 Feb 25.

13.

Molecular determinants of context-dependent progesterone receptor action in breast cancer.

Hagan CR, Lange CA.

BMC Med. 2014 Feb 20;12:32. doi: 10.1186/1741-7015-12-32. Review.

14.

Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor.

Chung HH, Sze SK, Woo AR, Sun Y, Sim KH, Dong XM, Lin VC.

J Biol Chem. 2014 Feb 28;289(9):5704-22. doi: 10.1074/jbc.M113.522839. Epub 2014 Jan 10.

15.

Post-translational modifications of the progesterone receptors.

Abdel-Hafiz HA, Horwitz KB.

J Steroid Biochem Mol Biol. 2014 Mar;140:80-9. doi: 10.1016/j.jsbmb.2013.12.008. Epub 2013 Dec 12. Review.

16.

Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.

Chung HH, Sze SK, Tay AS, Lin VC.

J Biol Chem. 2014 Jan 24;289(4):2180-94. doi: 10.1074/jbc.M113.517896. Epub 2013 Dec 3.

17.

Tracking progesterone receptor-mediated actions in breast cancer.

Knutson TP, Lange CA.

Pharmacol Ther. 2014 Apr;142(1):114-25. doi: 10.1016/j.pharmthera.2013.11.010. Epub 2013 Nov 26. Review.

18.

Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.

Lain AR, Creighton CJ, Conneely OM.

Mol Endocrinol. 2013 Oct;27(10):1743-61. doi: 10.1210/me.2013-1144. Epub 2013 Aug 26.

19.

A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.

Hagan CR, Knutson TP, Lange CA.

Nucleic Acids Res. 2013 Oct;41(19):8926-42. doi: 10.1093/nar/gkt706. Epub 2013 Aug 5.

20.

Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.

Wang S, Li Y, Hsu PH, Lee SY, Kim Y, Lee EY.

J Biol Chem. 2013 Sep 6;288(36):26265-74. doi: 10.1074/jbc.M113.476556. Epub 2013 Jul 23.

Supplemental Content

Support Center